Soaanz is owned by Sarfe Pharms.
Soaanz contains Torsemide.
Soaanz has a total of 1 drug patent out of which 0 drug patents have expired.
Soaanz was authorised for market use on 14 June, 2021.
Soaanz is available in tablet;oral dosage forms.
The generics of Soaanz are possible to be released after 06 October, 2033.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US10154963||SARFE PHARMS||Controlled-release formulations comprising Torsemide|| |
(10 years from now)
Drugs and Companies using TORSEMIDE ingredient
Market Authorisation Date: 14 June, 2021
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic